Dr. Reddy's Laboratories

Our manufacturing facilities have absorbed 250 apprentices into their front-line workforce through a meticulously crafted apprenticeship program over 15 months. The programme is designed to tap into a pool of diverse talent with qualifications spanning from Diploma to M. Pharm, aligning them with the specific needs of different business units. The most significant impact of this programme lies in its role as a talent pipeline builder. This provides a great model to address talent availability in niche skills and create a steady stream of skilled individuals ready to take on the challenges of tomorrow. At present, 680 apprentices are contributing across 16 units. We wish all our apprentices the best in this journey of contributing to our purpose of 'Good Health Can't Wait'.   #WeAreDrReddys #HumansOfDrReddys #GoodHealthCantWait  

Sathya Prathipati, Senior Partner at McKinsey & Company, moderated an illustrious panel of pharma industry luminaries at the Indian Pharmaceutical Alliance's 9th Global Pharmaceutical Quality Summit 2024. Leading the discussions were- MD & CEO of Cipla Umang Vohra; Co-chair of Dr Reddy’s Laboratories Prasad G V; Managing Director of Lupin Nilesh Gupta; Founder and CMD of Sun Pharmaceuticals Dilip Shanghvi, and Zydus Lifesciences Chairman, Pankaj Patel. In a lively discussion, panelists discussed pivotal strategies for the #pharmaceutical industry to advance significantly in the coming decade. Watch this space for more updates. #GPQS24 #GPQS2024 #pharma

Our team in Princeton, USA, has been observing #30DaysOfPride in solidarity with the global agenda of diversity, equity and inclusion (DEI). Our colleagues discussed the history of PRIDE, gender and allyship. They also provided LGBTQ+ resources to further self-education efforts and support. Pride-themed cupcakes, fruits and snacks were provided by local minority and women-owned businesses added to the occasion. Our DEI journey may be young but our colleagues across geographies continue to work towards being allies, celebrating diversity and embracing the unique contributions of every individual, beyond a single observance day or month. Through our ESG goals, we carry on our efforts to empower our colleagues and the community around us to build a more inclusive and welcoming environment.   #WeAreDrReddys #DrReddysXInclusivity #DEI #30DaysofPride #DrReddysXSustainability #GoodHealthCantWait

In a recent CEO round table organized by CII Telangana, our CEO, Akhil Ravi, along with other eminent industry leaders, shared their viewpoints on the 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐡𝐚𝐫𝐦𝐚 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐬𝐞𝐜𝐭𝐨𝐫. The panel also discussed the regulatory challenges and how Indian pharma services companies can look at new opportunities in the emerging geopolitical environment, specifically the recent moves around the 𝐁𝐢𝐨𝐬𝐞𝐜𝐮𝐫𝐞 𝐀𝐜𝐭 𝐛𝐲 𝐭𝐡𝐞 𝐔𝐒 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭. A heartfelt gratitude to Shilpa Reddy, Sudarshan Jain and Vikas Dandekar, for organizing and moderating this insightful round table! Telangana Lifesciences Indian Pharmaceutical Alliance CII Southern Region #pharmaceutical #biotech #ceoroundtable

Our Safety Health Environment & Sustainability (SHE & S) team concluded its observance of #WorldEnvironmentMonth this week across our manufacturing sites on a high note. In line with this year's theme around land restoration, stopping desertification and building drought resilience, we conducted 58 site walks for water management and 10 for energy conservation. 68 ambassadors conducted trainings on water and energy respectively. 894 colleagues enthusiastically participated in quizzes themed around water & environment compliance and energy last week. They also built a communication toolbox on energy conservation. Our Waste Management Ambassadors also addressed 160 students from Raghu College of Pharmacy, Pydibheemavarm. In collaboration with the Confederation of Indian Industry (CII), we also conducted a webinar on Energy and Climate change. Our manufacturing team in Bachupally, Hyderabad distributed over 75 native plant species across our plant site. Our efforts in environmental stewardship continue beyond a single observance day or month, as an organisation and as individuals! #WeAreDrReddys #DrReddysXSustainability #ESG #GoodHealthCantWait #SDG7 #SDG13

Today we took a significant step towards building our consumer healthcare business globally!   We have signed an agreement to acquire the global brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States from Haleon plc. The portfolio falls in the Nicotine Replacement Therapy (NRT) category. The portfolio to be acquired has an extensive footprint in over 30 countries globally, spanning Europe, Asia, Australia, Canada, and Latin America. Nicotinell is the second biggest brand globally (excluding the United States) in the NRT category, ranks among the top 15 biggest brands among all OTC brands in Europe (excluding Russia, Italy), and ranks 32 among all OTC global brands (excluding the U.S.). NRT is recommended by the ‘World Health Organization Model List of Essential Medicines’ for nicotine use disorders. NRT also played a key role in the WHO’s ‘Access Initiative for Quitting Tobacco’ launched in 2020 to help tobacco users quit to reduce the risk of severe outcomes from COVID-19 infection.   We continue to focus on our core business of generics, branded generics, API, OTC, and biosimilars. Alongside this, we have been investing in growth drivers of the future in three areas – access to novel molecules (NCEs, NBEs, CAR-T); digital therapeutics (wearables, apps); and consumer healthcare (including nutrition and OTC wellness products). Under consumer healthcare, in recent years, we have increased our presence in nutrition and OTC wellness in markets around the world including the U.S., UK, Emerging Markets and India, including a recent joint venture with Nestlé India. The acquisition of this global portfolio of consumer healthcare products led by the global brand Nicotinell is a logical extension of these efforts. Given the strong and steady performance of this portfolio over the years and its global advantages, it is the ideal anchor around which to build a larger global OTC platform. For more details, please visit: https://bit.ly/4cCJiiK #WeAreDrReddys #GoodHealthCantWait

For over three decades, our product Omez®(omeprazole) has been trusted by healthcare professionals and patients in India for Acid Peptic Disorders (APDs). Recently our team built further on this journey through some unique awareness initiatives under the ‘Acidity Free Life’ umbrella campaign. The journey began with our ‘Acidity Free Campaign’ in June 2023, steering conversations and rallying efforts to create a distinctive logo for 'World Acidity Day' which was selected by over 50,000+ healthcare professionals in India. To promote awareness about acidity prevention during long travel, the team reached out to over 10 lakh commuters in collaboration with Indian Railway Catering and Tourism Corporation (IRCTC) and Indian Railways. The campaign concluded with a unique sand art by Padma Shri Awardee Sudarsan Pattnaik at Puri Beach, showcasing our commitment to a healthier, acidity-free life! We are pleased to share that the campaign won “Most Innovative Campaign of the Year” award at the 13th Elets Healthcare Innovation Summit in India. Congratulations to the team, and we look forward to continuing to serve patients with innovative offerings.   #WeAreDrReddys #DrReddysXSustainability #SDG3 #GoodHealthCantWait #Beyond100

We look forward to our leaders representing us at the 9th Global Pharmaceutical Quality Summit, 2024, to be organised by the Indian Pharmaceutical Alliance on 27th-28th June in Mumbai! #IPA #GPQS24 #GoodHealthCantWait #WeAreDrReddys